Detection and Treatment of Hyperuricemia in Clinical Practice (According to the PROFILE Outpatient Registry)

Aim. To study the frequency of detection of hyperuricemia (HU) in patients with high and very high cardiovascular risk and the frequency of prescribing drugs that lower serum uric acid (sUA) levels in real clinical practice.Material and methods: The general information of the study was based on the...

Full description

Saved in:

Bibliographic Details
Main Authors:	N. P. Kutishenko, S. Yu. Martsevich, A. V. Zagrebelnyy, Yu. V. Lukina, V. P. Voronina, N. A. Dmitrieva, O. V. Lerman, S. N. Tolpygina, S. V. Blagodatskikh, I. V. Budaeva, E. S. Nekoshnova, O. M. Drapkina
Format:	Article
Language:	English
Published:	Столичная издательская компания 2022-09-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	uric acid hyperuricemia registry real clinical practice cardiovascular risk
Online Access:	https://www.rpcardio.online/jour/article/view/2796
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Challenges of Statin Therapy in Clinical Practice (According to Outpatient Register «PROFILE» Data)
by: S. Yu. Martsevich, et al.
Published: (2022-03-01)

Hyperuricemia: Features of the Diet
by: O. B. Shvabskaia, et al.
Published: (2022-01-01)

Adherence to therapy and the risk of cardiovascular events in patients with heart failure: data from the outpatient registry
by: E. T. Guseinova, et al.
Published: (2022-11-01)

AN OBESE PATIENT “PORTRAIT” BY THE RESULTS OF OUTPATIENT CARDIOVASCULAR REGISTRY “PROFILE”
by: A. V. Zakharova, et al.
Published: (2016-08-01)

Clinical and instrumental characteristics of osteoarthritis in hyperuricemia
by: E. A. Taskina, et al.
Published: (2024-10-01)

Long-term prognosis of life in patients with cerebrovascular accident: the role of diabetes mellitus (according to the REGION-M registry outpatient follow-up phase)
by: V. P. Voronina, et al.
Published: (2024-07-01)

Adherence to Attendance at Outpatient Clinic and Longterm Survival of Patients after Stroke in Outpatient Setting: the Data of REGION-M Registry
by: S. Yu. Martsevich, et al.
Published: (2021-07-01)

Asymptomatic hyperuricemia as a component of metabolic syndrome
by: I. D. Bespalova, et al.
Published: (2012-06-01)

COMPLIANCE TO CLINICIAN PRESCRIPTIONS IN ISCHEMIC HEART DISEASE PATIENTS (BY THE DATA FROM OUTPATIENT REGISTRY PROFILE)
by: Yu. V. Lukina, et al.
Published: (2017-03-01)

Long-term survival of patients after cerebrovascular accident with prior coronary artery disease: data from the outpatient stage of REGION-M registry
by: S. N. Tolpygina, et al.
Published: (2022-09-01)

NEW OPPORTUNITIES FOR CORRECTION OF HYPERURICEMIA IN GOUT
by: Svetlana Evgenyevna Myasoedova, et al.
Published: (2009-12-01)

Long-term survival of patients with cerebrovascular accident in different age groups in the REGION-M registry
by: S. N. Tolpygina, et al.
Published: (2023-03-01)

Association of hyperuricemia with dietary patterns and alcohol consumption in the adult population. Results of the ESSE-RF epidemiological study
by: N. S. Karamnova, et al.
Published: (2025-02-01)

THE EVALUATION OF ANTITHROMBOTIC TREATMENT PRESCRIPTION DYNAMICS IN PATIENTS WITH ATRIAL FIBRILLATION BY THE DATA OF PROFILE REGISTRY
by: S. Yu. Martsevich, et al.
Published: (2015-02-01)

Hyperuricemia—Especially “Metabolic Hyperuricemia”—Is Independently Associated with a Higher Risk of Steatotic Liver Disease
by: Janis Timsans, et al.
Published: (2025-05-01)

HYPERURICEMIA AND ITS CORRELATES IN THE RUSSIAN POPULATION (RESULTS OF ESSE-RF EPIDEMIOLOGICAL STUDY)
by: S. A. Shalnova, et al.
Published: (2015-09-01)

Hyperuricemia as a risk factor for cardiovascular events in hypertensive patients
by: I. A. Libov, et al.
Published: (2022-09-01)

Role of hyperuricemia in diabetic nephropathy
by: DENG Jie, WEI Jiali
Published: (2025-03-01)

Significance of asymptomatic hyperuricemia in ankylosing spondylitis
by: R. M. Balabanova, et al.
Published: (2021-06-01)

Guidelines "Medical registries. Role in evidence-based medicine. Recommendations for creation": a brief review
by: S. Yu. Martsevich, et al.
Published: (2023-07-01)

THE OUTPATIENT REGISTRY PROFILE UTILIZATION FOR OBESITY PATIENTS SURVEYING WITH THE AIM OF FOOD RELATED AND EXERCISE RELATED CARDIOVASCULAR RISK ASSESSEMENT
by: S. Yu. Martsevich, et al.
Published: (2017-08-01)

A narrative review of clinical evidence validating the efficacy of topiroxostat in managing hyperuricemia
by: S Chandrashekara, et al.
Published: (2022-01-01)

CLINICAL PRACTICE OF BETA-BLOCKERS USAGE IN PATIENTS WITH CARDIOVASCULAR AND CHRONIC RESPIRATORY DISEASES. DATA OF OUTPATIENT REGISTRIES PROFILE AND RECVASA
by: S. Yu. Martsevich, et al.
Published: (2017-09-01)

Patients with History of Myocardial Infarction and Acute Cerebrovascular Accidentin Clinical Practice: Demographic, Clinical Characteristics, Drug Treatment and Outcomes (Data of Outpatient and Hospital Registry REGION)
by: E. Yu. Okshina, et al.
Published: (2019-11-01)

Chronic kidney disease: the role of hyperuricemia and the possibility of urate-lowering therapy
by: M. S. Eliseev
Published: (2018-04-01)

Multifaceted hyperuricemia: modern approaches to diagnosis from the asymptomatic stage and the choice of treatment strategy
by: I. V. Kovaleva
Published: (2021-07-01)

Evaluating Adherence to Medical Therapy in Patients with Chronic Heart Failure: Design and First Results of the COMPLIANCE Study
by: S. Yu. Martsevich, et al.
Published: (2020-09-01)

Study of the Quality of Medical Therapy and Adherence in Patients with Chronic Heart Failure (According to the COMPLIANCE Study)
by: E. T. Guseynova, et al.
Published: (2021-11-01)

LIS-3 Acute Coronary Syndrome Registry: Changes in Clinical and Demographic Characteristics and Tactics of Prehospital and Hospital Treatment of Surviving Patients After Acute Coronary Syndrome Over a 4-Year Period
by: S. Yu. Martsevich, et al.
Published: (2020-05-01)

Effects of bioactive peptides combined with probiotics on serum uric acid in patients with hyperuricemia
by: HAN Dan，ZHAO Ya，HUANG Enshan，YE Shuhua，WANG Wanjin，WU Fangmin，WANG Dingliang，ZHANG Ronghua
Published: (2025-01-01)

Risk factors for type 2 diabetes mellitus in patients with gout: results from a prospective study
by: O. V. Zhelyabina, et al.
Published: (2022-02-01)

The association between smoking and the occurrence of hyperuricemia: A retrospective cohort study
by: Peihua Li<sup>+<sup>, et al.
Published: (2025-05-01)

The Study of Adherence to Drug Therapy at the Stage of Outpatient Follow-up in Patients with Acute Myocardial Infarction (Data from the PROFIL-IM Registry)
by: E. P. Kalaydzhyan, et al.
Published: (2023-03-01)

Current issues in the practical use of allopurinol in patients with gout and hyperuricemia
by: M. S. Eliseev
Published: (2024-10-01)

The Main Cardiovascular Complications and Mortality Rates During the First One and a Half Years after Acute Myocardial Infarction: Data from the Prospective Outpatient Registry PROFILE-IM
by: S. Yu. Martsevich, et al.
Published: (2020-07-01)

Long-term survival of patients with cerebrovascular accident, depending on sex and age: data from the REGION-M registry
by: S. N. Tolpygina, et al.
Published: (2023-09-01)

Unveiling the therapeutic benefits of black chokeberry (Aronia melanocarpa) in alleviating hyperuricemia in mice
by: Chin-Yuan Liu, et al.
Published: (2025-05-01)

Effect of Pingyanghuangtang tea on hyperuricemia in mice and its mechanism
by: LOU Zhenyou, et al.
Published: (2024-08-01)

Febuxostat efficiently reduces the progression of chronic kidney disease in asymptomatic hyperuricemia: an interventional study
by: Showkat Azad, et al.
Published: (2025-04-01)

The association between the cardiometabolic index and hyperuricemia: 2011–2016 NHANES
by: Yishan Zhou, et al.
Published: (2025-05-01)